AnalystsRandall StanickyRandall Stanicky's Stock Forecasts
AnalystsRandall Stanicky
Analyst Ranking
Bottom 22%
#3571 out of 4554 analysts
Average Return
-1.39%
Win Rate
50%7 out of 14
Risk vs Reward
Poor
Good
Randall Stanicky's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Abbvie IncABBV | +29.81% | $83.99 | $109.03 | 2020-04-19 - 2021-04-20 | Buy |
Abbvie IncABBV | +29.60% | $108.53 | $140.65 | 2021-02-03 - 2022-02-04 | Buy |
Abbvie IncABBV | +28.08% | $105.58 | $135.23 | 2021-01-05 - 2022-01-06 | Buy |
Abbvie IncABBV | +25.10% | $92.26 | $115.42 | 2020-06-10 - 2021-06-11 | Buy |
Pfizer IncPFE | +22.46% | $30.90 | $37.84 | 2020-03-26 - 2020-12-16 | Buy |
Randall Stanicky Analyst Color
Get additional color on Randall Stanicky's coverage of popular stocks
Randall Stanicky's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rvl Pharmaceuticals PLCRVLPQ | 1 | Buy | $8.00 | N/A | Maintains | 3 years ago |
Abbvie IncABBV | 8 | Buy | $135.00 | N/A | Maintains | 3 years ago |
Perrigo Co PLCPRGO | 4 | Hold | $49.00 | N/A | Downgrades | 3 years ago |
Pfizer IncPFE | 2 | Hold | $42.00 | N/A | Downgrades | 3 years ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Buy | $180.00 | N/A | Maintains | 3 years ago |
Merck & Co IncMRK | 1 | Hold | $89.00 | N/A | Maintains | 4 years ago |
Agile Therapeutics IncAGRX | 1 | Buy | $16,000.00 | N/A | Maintains | 4 years ago |
Amneal Pharmaceuticals IncAMRX | 1 | Hold | $4.00 | N/A | Maintains | 4 years ago |
Optinose IncOPTN | 1 | Buy | $33.00 | N/A | Initiates Coverage On | 6 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Sell | N/A | N/A | Downgrades | 7 years ago |
Pacira Biosciences IncPCRX | 1 | Buy | $58.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.